首页> 中文期刊> 《检验医学与临床》 >18F-脱氧葡萄糖符合线路SPECT/CT显像在肿瘤患者随访中的临床价值

18F-脱氧葡萄糖符合线路SPECT/CT显像在肿瘤患者随访中的临床价值

         

摘要

目的 探讨18F-脱氧葡萄糖(18F-FDG)符合线路SPECT/CT 显像检查在诊断肿瘤患者放疗后复发及转移的临床价值.方法 对该院60例疑似复发和转移的癌症患者行18F-FDG符合线路 SPECT/CT 显像,并将此结果同病理检查结果进行比较.结果 病理结果显示有50例患者均发生肿瘤治疗后的复发或转移.18F-FDG符合线路SPECT/CT 显像显示45例为阳性患者,与病理检查结果比较,该方法监测肿瘤复发及转移的灵敏度、特异度、准确度分别为86.5%、100.0%、88.3%.结论 18F-FDG 符合线路 SPECT/CT 显像对监测肿瘤患者的复发和转移,具有较高的灵敏度和特异度,可及时发现病灶,值得临床推广与应用.%Objective To discuss the evaluation of clinical application of 18F-FDG SPECT/CT coincidence imaging on patients with carcinoma after radiotherapy during follow-up period.Methods The 60 patients with carcinoma after radiotherapy or chemotherapy were studied using 18F-FDG SPECT/CT coincidence imaging, and these results were compared with the pathological results.Results The 18F-FDG SPECT/CT coincidence imaging showed a positive result in 45 patients with recurrence or metastasis.And the diagnosis sensitivity, specsificity and accuracy were 86.5%,100.0%,88.3% respectively.Conclusion 18F-FDG SPECT/CT coinci-dence imaging can evaluate the therapentic effects of radiotherapy on patients with nasopharyngeal carcinoma, and detect the lesions of recurrence or metastasis,and worthy to be popularized for clinical use.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号